Bordetella Pertussis Toxin vs Pembrolizumab

## Bordetella Pertussis Toxin vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Bordetella Pertussis Toxin** and **Pembrolizumab**.

## Mechanism of Action

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Bordetella Pertussis Toxin — N/A; Pembrolizumab — 26 days.

## Chemical Properties

**Type**: Bordetella Pertussis Toxin — Vaccine component; Pembrolizumab — Antibody.